Cell Source, Inc. Quarterly Operating Income (Loss) in USD from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Cell Source, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2014 to Q2 2024.
  • Cell Source, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$1.19M, a 31.8% decline year-over-year.
  • Cell Source, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$4.34M, a 1.67% increase year-over-year.
  • Cell Source, Inc. annual Operating Income (Loss) for 2023 was -$4.33M, a 3.59% decline from 2022.
  • Cell Source, Inc. annual Operating Income (Loss) for 2022 was -$4.18M, a 3.9% decline from 2021.
  • Cell Source, Inc. annual Operating Income (Loss) for 2021 was -$4.02M, a 10.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$4.34M -$1.19M -$288K -31.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-19
Q1 2024 -$4.05M -$1.14M +$277K +19.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-07-29
Q4 2023 -$4.33M -$1.01M +$63.8K +5.95% Oct 1, 2023 Dec 31, 2023 10-K 2024-06-24
Q3 2023 -$4.39M -$995K +$20.7K +2.03% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$4.41M -$905K +$128K +12.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-19
Q1 2023 -$4.54M -$1.42M -$363K -34.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-07-29
Q4 2022 -$4.18M -$1.07M -$486K -82.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-06-24
Q3 2022 -$3.69M -$1.02M +$299K +22.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$3.99M -$1.03M -$38.8K -3.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-09-19
Q1 2022 -$3.95M -$1.05M +$68.7K +6.13% Jan 1, 2022 Mar 31, 2022 10-Q 2023-08-23
Q4 2021 -$4.02M -$587K +$249K +29.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-08-08
Q3 2021 -$4.27M -$1.32M -$150K -12.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-12-08
Q2 2021 -$4.12M -$995K -$91.8K -10.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-12-02
Q1 2021 -$4.03M -$1.12M -$388K -52.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-02
Q4 2020 -$3.64M -$836K -$271K -48.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-15
Q3 2020 -$3.37M -$1.17M +$195K +14.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$3.56M -$903K -$195K -27.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$3.37M -$733K +$438K +37.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$3.81M -$564K -$131K -30.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-15
Q3 2019 -$3.67M -$1.36M -$872K -179% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 -$2.8M -$709K -$285K -67.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$2.52M -$1.17M -$511K -77.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$2.01M -$433K +$174K +28.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 -$2.18M -$489K +$66.5K +12% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$2.25M -$424K +$223K +34.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$2.47M -$660K -$177K -36.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-20
Q4 2017 -$2.29M -$607K Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 -$555K +$46.6K +7.74% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$647K -$116K -22% Apr 1, 2017 Jun 30, 2017 10-Q 2018-10-18
Q1 2017 -$484K +$161K +25% Jan 1, 2017 Mar 31, 2017 10-Q 2018-10-18
Q3 2016 -$602K -$52.6K -9.58% Jul 1, 2016 Sep 30, 2016 10-Q 2018-07-25
Q2 2016 -$530K +$37.6K +6.62% Apr 1, 2016 Jun 30, 2016 10-Q 2018-07-25
Q1 2016 -$645K -$56.9K -9.69% Jan 1, 2016 Mar 31, 2016 10-Q 2018-07-25
Q3 2015 -$549K +$166K +23.2% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-18
Q2 2015 -$568K +$449K +44.2% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$588K +$185K +23.9% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q3 2014 -$715K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 -$1.02M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-11
Q1 2014 -$773K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.